Literature DB >> 22081466

[Prevalence, comorbidity and severity of psychosomatic disorders in outpatients with Turkish migration background].

Yesim Erim1, Eva Morawa, Dilsad Foto Ozdemir, Wolfgang Senf.   

Abstract

In this study the prevalence and comorbidity of mental disorders were examined for the first time with the Structured Clinical Interview for DSM-IV (SCID-I) in a consecutive sample of Turkish speaking patients (n=51). The symptom severity of the depressiveness was measured with the Beck Depression Inventory (BDI), of the somatoform complaints with the Screening for Somatoform Symptoms (SOMS) and of the posttraumatic stress disorder (PTSD) with the Essen Trauma Inventory (ETI). The most common current diagnoses were the somatization disorder (41.2%; n=21), a single episode of major depression (37.3%; n=19) and the PTSD (31.4%; n=16). In 80.4% (n=41) of the patients at least one comorbid mental disorder was documented. In comparison with German reference values the Turkish patients showed a significant higher severity of the depressive and posttraumatic, however not of the somatoform symptomatology. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 22081466     DOI: 10.1055/s-0031-1291274

Source DB:  PubMed          Journal:  Psychother Psychosom Med Psychol        ISSN: 0937-2032


  10 in total

1.  Motivation for Psychotherapy and Illness Beliefs in Turkish Immigrant Inpatients in Germany: Results of a Cultural Comparison Study.

Authors:  Hanna Reich; Luisa Bockel; Ricarda Mewes
Journal:  J Racial Ethn Health Disparities       Date:  2014-10-01

2.  [Prevalence of mental disorders in multimodal therapy of chronic back pain].

Authors:  J Artner; F Lattig; B Cakir; H Gündel; H Reichel; J A Spiekermann
Journal:  Orthopade       Date:  2012-12       Impact factor: 1.087

3.  Awareness and use of psychosocial care among cancer patients and their relatives-a comparison of people with and without a migration background in Germany.

Authors:  Susanne Singer; Nicola Riccetti; Isabelle Hempler; Marius Fried; Jorge Riera Knorrenschild; Louma Kalie; Martin Merbach; Marcel Reiser; Franz Mosthaf; Vitali Heidt; Kerstin Hermes-Moll
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-11       Impact factor: 4.322

4.  Associations Between Acculturation, Depressive Symptoms, and Life Satisfaction Among Migrants of Turkish Origin in Germany: Gender- and Generation-Related Aspects.

Authors:  Eva Morawa; Tilman Brand; Nico Dragano; Karl-Heinz Jöckel; Susanne Moebus; Yesim Erim
Journal:  Front Psychiatry       Date:  2020-07-30       Impact factor: 4.157

5.  [Mental distress in primary care patients: German patients compared with patients of Turkish origin].

Authors:  S Sariaslan; E Morawa; Y Erim
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

6.  Acculturation and depressive symptoms among Turkish immigrants in Germany.

Authors:  Eva Morawa; Yesim Erim
Journal:  Int J Environ Res Public Health       Date:  2014-09-12       Impact factor: 3.390

7.  High Manifestations of Mental Distress in Arabic Asylum Seekers Accommodated in Collective Centers for Refugees in Germany.

Authors:  Ekaterini Georgiadou; Eva Morawa; Yesim Erim
Journal:  Int J Environ Res Public Health       Date:  2017-06-07       Impact factor: 3.390

8.  Effectiveness of Inpatient Psychotherapy for Patients With and Without Migratory Background: Do They Benefit Equally?

Authors:  Friederike Kobel; Eva Morawa; Yesim Erim
Journal:  Front Psychiatry       Date:  2020-06-11       Impact factor: 4.157

9.  Acculturation and other risk factors of depressive disorders in individuals with Turkish migration backgrounds.

Authors:  Hanna Janssen-Kallenberg; Holger Schulz; Ulrike Kluge; Jens Strehle; Hans-Ulrich Wittchen; Uwe Wolfradt; Uwe Koch-Gromus; Andreas Heinz; Mike Mösko; Demet Dingoyan
Journal:  BMC Psychiatry       Date:  2017-07-19       Impact factor: 3.630

10.  Predictors for successful psychotherapy: Does migration status matter?

Authors:  Friederike Kobel; Yesim Erim; Eva Morawa
Journal:  PLoS One       Date:  2021-09-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.